Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study

SZ Goldhaber, W Ageno, IB Casella, KH Chee… - Journal of thrombosis …, 2022 - Springer
Abstract RE-COVERY DVT/PE is a two-phase, international, observational study of
anticoagulant therapy in patients with deep vein thrombosis and/or pulmonary embolism …

Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study

SZ GOLDHABER, W AGENO… - … of Thrombosis and …, 2022 - observatorio.fm.usp.br
RE-COVERY DVT/PE is a two-phase, international, observational study of anticoagulant
therapy in patients with deep vein thrombosis and/or pulmonary embolism (DVT/PE). The …

Safety and effectiveness of dabigatran in routine clinical practice: The RE-COVERY DVT/PE study

SZ Goldhaber, W Ageno, IB Casella… - … of Thrombosis And …, 2022 - eprints.um.edu.my
RE-COVERY DVT/PE is a two-phase, international, observational study of anticoagulant
therapy in patients with deep vein thrombosis and/or pulmonary embolism (DVT/PE). The …

Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study

SZ Goldhaber, W Ageno, IB Casella… - … of thrombosis and …, 2021 - mymedr.afpm.org.my
Abstract RE-COVERY DVT/PE is a two-phase, international, observational study of
anticoagulant therapy in patients with deep vein thrombosis and/or pulmonary embolism …

Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study.

SZ Goldhaber, W Ageno, IB Casella… - … of Thrombosis and …, 2021 - europepmc.org
RE-COVERY DVT/PE is a two-phase, international, observational study of anticoagulant
therapy in patients with deep vein thrombosis and/or pulmonary embolism (DVT/PE). The …

Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study

SZ Goldhaber, W Ageno, IB Casella, KH Chee… - Journal of Thrombosis …, 2021 - elibrary.ru
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE
study КОРЗИНА ПОИСК НАВИГАТОР СЕССИЯ КОНТАКТЫ ИНФОРМАЦИЯ О …

Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study

SZ Goldhaber, W Ageno, IB Casella… - JOURNAL OF …, 2021 - irinsubria.uninsubria.it
Abstract RE-COVERY DVT/PE is a two-phase, international, observational study of
anticoagulant therapy in patients with deep vein thrombosis and/or pulmonary embolism …

Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study

SZ Goldhaber, A Walter, IB Casella… - … of Thrombosis and …, 2022 - search.proquest.com
Abstract RE-COVERY DVT/PE is a two-phase, international, observational study of
anticoagulant therapy in patients with deep vein thrombosis and/or pulmonary embolism …

Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study

SZ Goldhaber, W Ageno, IB Casella… - … of thrombosis and …, 2022 - pubmed.ncbi.nlm.nih.gov
RE-COVERY DVT/PE is a two-phase, international, observational study of anticoagulant
therapy in patients with deep vein thrombosis and/or pulmonary embolism (DVT/PE). The …

Safety and effectiveness of dabigatran in routine clinical practice: The RE-COVERY DVT/PE study

SZ Goldhaber, W Ageno, IB Casella… - … of Thrombosis And …, 2022 - eprints.um.edu.my
RE-COVERY DVT/PE is a two-phase, international, observational study of anticoagulant
therapy in patients with deep vein thrombosis and/or pulmonary embolism (DVT/PE). The …